Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19
Simin Aysel Florescu, Dragos Stanciu, Mihaela Zaharia, et al.
JAMA (2023) Vol. 329, Iss. 14, pp. 1183-1183
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Sepsis-associated acute kidney injury: recent advances in enrichment strategies, sub-phenotyping and clinical trials
Matthieu Legrand, Sean M. Bagshaw, Pavan K. Bhatraju, et al.
Critical Care (2024) Vol. 28, Iss. 1
Open Access | Times Cited: 13
Simvastatin in Critically Ill Patients with Covid-19
Thomas Hills, Elizabeth Lorenzi, Lindsay R. Berry, et al.
New England Journal of Medicine (2023) Vol. 389, Iss. 25, pp. 2341-2354
Open Access | Times Cited: 32
The Rise of Adaptive Platform Trials in Critical Care
Lieuwe D. J. Bos, Carolyn S. Calfee, Andrea Castellví-Font, et al.
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 209, Iss. 5, pp. 491-496
Open Access | Times Cited: 7
Renin-Angiotensin System and Sex Differences in COVID-19: A Critical Assessment
Mark C. Chappell
Circulation Research (2023) Vol. 132, Iss. 10, pp. 1320-1337
Open Access | Times Cited: 17
The alternative renin–angiotensin system in critically ill patients: pathophysiology and therapeutic implications
Bruno Garcia, Alexander Zarbock, Rinaldo Bellomo, et al.
Critical Care (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 15
Vascular manifestations of COVID-19: Endothelial dysfunction and damage
Paula Poyatos, Miquel Gratacós, Sana Ayyoub, et al.
Elsevier eBooks (2025), pp. 323-334
Closed Access
Mechanisms, Biomarkers, and Treatment Approaches for Diabetic Kidney Disease: Current Insights and Future Perspectives
Jean Paule Joumaa, Angela Raffoul, Claudia Sarkis, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 3, pp. 727-727
Open Access
Endocan as a marker of endotheliitis in COVID-19 patients: modulation by veno-venous extracorporeal membrane oxygenation, arterial hypertension and previous treatment with renin–angiotensin–aldosterone system inhibitors
Marta Reina‐Couto, D. Castro Alves, Carolina Silva-Pereira, et al.
Inflammation Research (2025) Vol. 74, Iss. 1
Open Access
Incidence and pathological features of IgA nephropathy before and during the COVID-19 pandemic
Wen Liu, Ricong Xu, Di Wu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Modulation of the Renin-Angiotensin System against COVID-19: A path forward?
Serge Camelo, Waly Dioh, J. Pedro Teixeira, et al.
International Journal of Infectious Diseases (2025), pp. 107867-107867
Open Access
Extending the ‘host response’ paradigm from sepsis to cardiogenic shock: evidence, limitations and opportunities
Marie Buckel, Patrick Maclean, Julian C. Knight, et al.
Critical Care (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 12
Angiotensin II treatment is associated with improved oxygenation in ARDS patients with refractory vasodilatory shock
Daniel E. Leisman, Damian Handisides, Lakhmir S. Chawla, et al.
Annals of Intensive Care (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Relationship between 2nd-generation angiotensin receptor blockers and the risk of hypotension in COVID-19 patients admitted to hospital
Fumiki Yoshihara, Yasushi Matsuzawa, Kiyomasa Nakatsuka, et al.
Hypertension Research (2024) Vol. 47, Iss. 7, pp. 1943-1951
Closed Access | Times Cited: 3
Effects of Losartan on Patients Hospitalized for Acute Coronavirus Disease 2019: A Randomized Controlled Trial
Karen Tran, Pierre Asfar, Matthew P. Cheng, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 3, pp. 615-625
Closed Access | Times Cited: 3
Standard of care plus telmisartan on respiratory failure due to COVID-19 (STAR-COVID trial)
Abraham Edgar Gracia‐Ramos, Gissel Y. ÁNGELES-DURÁN, Iván R. Flores-Gómez, et al.
Minerva Cardiology and Angiology (2024) Vol. 72, Iss. 2
Closed Access | Times Cited: 2
Subgroup analyses and heterogeneity of treatment effects in randomized trials: a primer for the clinician
Alexandra B. Spicer, Alexandre Biasi Cavalcanti, Fernando G. Zampieri
Current Opinion in Critical Care (2024) Vol. 30, Iss. 5, pp. 427-438
Closed Access | Times Cited: 2
Angiotensin-(1–7) infusion in COVID-19 patients admitted to the ICU: a seamless phase 1–2 randomized clinical trial
Ana Luiza Valle Martins, Filippo Annoni, Filipe Alex da Silva, et al.
Annals of Intensive Care (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Blood ACE2 protein level correlates with COVID-19 severity
О. О. Шевчук, A S Pak, Svitlana Palii, et al.
(2023)
Open Access | Times Cited: 7
Role of the Renin-Angiotensin System in Long COVID’s Cardiovascular Injuries
Elena Cojocaru, Cristian Cojocaru, Cristiana-Elena Vlad, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 2004-2004
Open Access | Times Cited: 7
Alveolar Hyperoxia and Exacerbation of Lung Injury in Critically Ill SARS-CoV-2 Pneumonia
Ahilanandan Dushianthan, Luke Bracegirdle, Rebecca Cusack, et al.
Medical Sciences (2023) Vol. 11, Iss. 4, pp. 70-70
Open Access | Times Cited: 7
Blood ACE2 Protein Level Correlates with COVID-19 Severity
О. О. Шевчук, A S Pak, Svitlana Palii, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13957-13957
Open Access | Times Cited: 6
Effects of renin–angiotensin system blockers on outcomes from COVID-19: a systematic review and meta-analysis of randomized controlled trials
Matthew M.Y. Lee, Toru Kondo, Ross T. Campbell, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2023) Vol. 10, Iss. 1, pp. 68-80
Open Access | Times Cited: 5
Anti-PD-L1 therapy altered inflammation but not survival in a lethal murine hepatitis virus-1 pneumonia model
Colleen S. Curran, Xizhong Cui, Yan Li, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 1
Investigation of Strategies to Block Downstream Effectors of AT1R-Mediated Signalling to Prevent Aneurysm Formation in Marfan Syndrome
Irene Valdivia Callejon, Lucia Buccioli, Jarl Bastianen, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 5025-5025
Open Access | Times Cited: 1
Effect of apigetrin in pseudo-SARS-CoV-2-induced inflammatory and pulmonary fibrosis in vitro model
Hengmin Han, Jung-Eun Kim, Hyo‐Jeong Lee
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top